Нечаева О.Б. Влияние ВИЧ-инфекции на эпидемическую ситуацию по туберкулезу в России // Туберкулез и социально-значимые заболе- вания. 2015. № 4. С. 69–70. [Nechaeva O.B. HIV affect the TB epidemic situation in Russia. Tuberculosis and Socially-Determined Diseases, 2015, No. 4, pp. 69–70 (In Russ.)].
Галкин В.Б., Баласанянц Г.С., Белиловский Е.М., Яблонский П.К. Оценка динамики численности заболевших туберкулезом в странах с наибольшим бременем туберкулеза // Медицинский альянс. 2015. № 1. С. 25–26. [Galkin V.B., Balasanyants G.S., Belilovskiy E.M., Yablonskiy P.K. Estimation of the new TB cases in the process in countries with a highest TB burden. Medical Alliance, 2015, No. 1, pp. 25–26 (In Russ.)].
Global tuberculosis report 2014. Geneva: World Health Organization, 2015.
A guide to monitoring and evaluation for collaborative TB/HIV activities: 2015 revision. Geneva: WHO, 2015, 44 p.
WHO policy on collaborative TB/HIV activities. Guidelines for national programs and other stakeholders. Geneva: WHO, 2012, 36 p.
Gupta S.S., Granich R., Suthar A.B., Smyth S., Baggaley R., Sculler D., Date A., Desai M.A., Lule F., Raizes E., Blanc L., McClure C., Hirnschall G. Three I’s for HIV/TB and early ART to prevent HIV and TB: policy review of HIV and TB guidelines for high HIV/TB-burden African countries. Nineteenth International AIDS Conference, Washington DC, 2012, WEPDD0205.
World Health Organization, Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource constrained settings. Geneva: WHO, 2015.
Химиопрофилактика туберкулеза // Методическое письмо № 10-87/14-1 от 30.05.1962. М., 1962. [Chemoprophylaxis of Tuberculosis. Methodical Letter No. 10-87/14-1 from 30.05.1962, Moscow, 1962 (In Russ.)].
Инструкция «Химиопрофилактика туберкулеза» // Приказ Министерства здравоохранения СССР от 24.03.1988 № 06-14/11-14. М., 1988. [Instruction «Chemoprophylaxis of Tuberculosis». Order of the Ministry of Health of the USSR from 24.03.1988 No. 06-14/11-14, Moscow, 1988 (In Russ.)].
Профилактика и лечение сопутствующих заболеваний (туберкулеза, вирусных гепатитов и ИППП) у взрослых и подростков, больных ВИЧ-инфекцией: Методические рекомендации // Приказ Минздравсоцразвития РФ от 29.12.2006 № 7126-РХ. М., 2006. 41 c. [Methodical Guidelines «Prevention and treatment of co-morbidity (tuberculosis, viral hepatitis and STD) among adults and adolescents, infected by HIV». Order of Health Care and Social Support Ministry of Russian Federation from 29.12.2006 No. 7126-PX, Moscow, 2006, 41 р. (In Russ.)].
Фролова О.П., Кравченко А.В., Мартынов А.А., Батыров Ф.А. Организация противотуберкулезной помощи больным ВИЧ-инфекцией: пособие для врачей // М.; Тверь: Триада. 2007. 120 c. [Frolova O.P., Kravchenko A.V., Martynov A.A., Batyrov F.A. TB control in HIV-infected people: handbook for clinicians. Moscow; Tver: Triada, 2007, 120 p. (In Russ.)].
Турсунова Н.А., Ворожцова М.П. Профилактическая работа фтизиатра в Городском центре по профилактике и борьбе со СПИДом: Актуальные вопросы диагностики и лечения туберкулеза / Под ред. Ю.Н.Левашева. СПб., 2005. С. 60–65. [Tursunova N.A., Vorogtsova M.P. TB preventive work of phthisiatrician at the City AIDS Center: Current issues in diagnosis and treatment of tuberculosis. Ed. Yu.N.Levaschov. Saint-Petersburg, 2005, pp. 60–65 (In Russ.)].
Белякова Н.В., Фролова О.П., Золотарева Л.В., Новоселова O.A. Анализ состояния заболеваемости туберкулезом среди больных ВИЧ-инфекцией (на примере пяти областей Центрального федерального округа) // Эпидемиология и вакцинопрофилактика. 2010. № 5. С. 54–59. [Belyakova N.V., Frolova O.P., Zolotareva L.V., Novoselova O.A. Evaluation of the TB incidence in HIV-infected patients (in frame of five territories in Central Federal Region). Epydemiology and Vaccine Рrevention, 2010, No. 5, рр. 54–59 (In Russ.)].
Бурлина Е.В., Эйсмонт Н.В., Подымова А.С., Рямова Е.П. Результаты превентивного лечения туберкулеза у больных с поздними стадиями ВИЧ-инфекции в Свердловской области // Туберкулез и болезни легких. 2011. № 4. С. 74–75. [Burlinа E.V., Eysmont N.V., Podymova A.S., Pyamova E.P. Results of TB preventive treatment in HIV-infected patients with proficient stages in Sverdlovskiy oblast. Tuberculosis and Lung Diseases, 2011, No. 4, pp. 74–75 (In Russ.)].
Нарышкина С.Л., Алексеева Т.В., Ревякина О.В. Химиопрофилактика туберкулеза у больных ВИЧ-инфекцией // Проблемы туберкулеза у больных ВИЧ-инфекцией. 2013. № 12. С. 49–50. [Naryschkina S.L., Alexeeva T.V., Revyakina O.V. Chemoprophylaxis of TB in HIV infected patients. TB Problems in HIV Infected Patients, 2013, No. 12, pp. 49–50(In Russ.)].
Хорошутина В.В., Белоносова Е.Н. Опыт проведения химиопрофилактики туберкулеза у больных ВИЧ-инфекцией // Проблемы туберкулеза у больных ВИЧ-инфекцией. 2013. № 12. С. 50. [Choroshutina V.V., Belonosova E.N. Experience of providing TB chemoprophylaxis in HIV infected patients. TB Problems in HIV Infected Patients, 2013, No. 12, pp. 50 (In Russ.)].
Henok Tadesse Ayele, Maaike S.M. van Mourik, Thomas P.A. Debray, Marc J.M. Bonten. Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials. PLoS Med. 2015, November 9, URL: http://dx.doi.org/10.1371/journal.pone.0142290..
DOI: 10.1371/journal.pone.0142290
Akolo C., Adetifa I., Shepperd S., Volmnik J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database of Systematic Reviews, 2010, No. 1, CD000171, DOI: 10.1002/14651858.CD000171.pub3..
DOI: 10.1002/14651858.CD000171.pub3
Sterling T.R., Villarino M.E., Borisov A.S., Shang N., Gordin F., Bliven-Sizemore E., Hackman J., Hackman J., Hamilton C.D., Menzies D., Kerrigan A., Weis S.E., Weiner M., Wing D., Conde M.B., Bozeman L., Horsburgh C.R. Jr., Chaisson R.E. Three months of once-weekly rifapentine and isoniazid for M. tuberculosis infection. N. Engl. J. Med., 2011, No. 365, pp. 2155–2166.
Centers of Disease Control and Prevention. Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection. Morb. Mortal. Wkly Rep., 2011, Vol. 60, No. 48, pp. 1650–1653.
Martinson N.A., Barnes G.L., Moulton L.H., Msandiwa R., Hausler H., Ram M., McIntyre J.A., Gray G.E., Chaisson R.E. New Regimens to Prevent Tuberculosis in Adults with HIV Infection. N. Engl. J. Med., 2011, Vol. 365, No. 1, pp. 11–20.
Martinson N.B., Barnes G., Msandiwa R., Moulton L., Gray G., McIntyre J., Pronyk P., Chaisson R.E. Novel regimens for treating latent TB in HIV-infected adults in South Africa: a randomized clinical trial. Program and Abstracts of Conference on Retroviruses and Opportunistic Infections, Montreal, Canada, 8–11 February 2009, pp. 36bLB.
Gordin F. Rifampin and Pyrazinamide vs Isoniazid for Prevention of Tuberculosis in HIV-Infected Persons: An International Randomized Trial. JAMA. J. Am. Med. Ass., 2000, Vol. 283, No. 11, pp. 1445–1450.
Whalen C.C., Johnson L.L., Okwera A., Hom D.L., Huebner R., Mugyenyl P., Mugerwa R.D., Ellner J.J. A trail of three regimens to prevent tuberculosis in Ugandan adults infected with the Human Immunodeficiency Virus. N. Engl. J. Med., 1997, No. 337, pp. 12.
Беляков Н.А., Левина О.С., Рыбников В.Ю. Формирование приверженности к лечению у больных с ВИЧ-инфекцией // ВИЧ-инфекция и иммуносупрессии. 2013. Т. 5, № 1. С. 7–33. [Belyakov N.A., Levina O.S., Rybnikov V.Yu. Forming a treatment adherence in HIV Infected patients. HIV Infection and Immunosuppressive Disorders, 2013, Vol. 5, No. 1, pp. 7–33(In Russ.)].
Приказ МЗ и СР РФ от 09.07.07 № 475 «Об утверждении стандарта медицинской помощи больным болезнью, вызванной вирусом имму- нодефицита человека (ВИЧ) (при оказании специализированной помощи)». М., 2007. [The Medical care standards to patients with diseases caused by human immunodeficiency virus (HIV) (specialized care). Order of the Health Care and Social Support Ministry of Russian Federation No. 475 of July 9, 2007, Moscow, 2007 (In Russ.)].
Приказ МЗ и СР РФ от 09.07.07 г. № 474 «Об утверждении стандарта медицинской помощи больным болезнью, вызванной вирусом иммуно- дефицита человека (ВИЧ)». M., 2007. [The Medical care standards to patients with diseases caused by human immunodeficiency virus (HIV) (outpatient care). Order of the Health Care and Social Support Ministry of Russian Federation No. 474 of July 9, 2007, Moscow, 2007 (In Russ.)].
Pape J.W., Jean S.S., Ho J.L., Hafner A. and Johnson W.D. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet, 1993, Vol. 342, No. 8866, pp. 268–272.
Churchyard G.J., Fielding K.L., Lewis J.J., Coetzee L., Corbett E.L., Godfrey-Faussett P., Hayes R.J., Chaisson R.E., Grant A.D. A trial of mass isoniazid preventive therapy for tuberculosis control. N. Engl. J. Med., 2014, Vol. 370, No. 4, pp. 301–310.
Ayele H.T., van Mourik M.S. and Bonten M.J. Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: are prospective cohort study. BMC Infect. Dis., 2015, Vol. 15, No. 1, pp. 334.
Assebe L.F., Reda H.L., Wubeneh A.D., Lerebo W.T. and Lamber S.M. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study. BMC Public Health, 2015, No. 15, pp. 346.
Quigley M.A., Mwinga A., Hosp M., Lisse I., Fuchs D., Porter T. Long term effectof preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults. AIDS, 2001, No. 15, pp. 215–222.
Golub J.E., Saraceni V., Cavalcante S.C., Pacheco A.G., Moulton L.H., King B.S., Efron A., Moors D., Chaisson R.E., Durovi B. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV infected patients in Rio de Janeiro, Brazil. AIDS, 2007, No. 21, pp. 1441–1448.
Temprano ANRS Study Group. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N. Engl. J. Med., 2015, published online Aug 27, DOI: 10.1056/NEJMoa1507198..
DOI: 10.1056/NEJMoa1507198
Golub J.E., Pronyk P., Mohapi L., Thsabangu N., Moshabela M., Struthers H., Gray G.E., McIntyre J.A., Chaisson R.E., Martinson N.A. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS, 2009, No. 23, pp. 631–636.
Rangaka M.X., Wilkinson R.J., Boulle A., Glynn J.R., Fielding K., van Cutsem G., Wilkinson K.A., Goliath R., Mathee S., Goemaere E., Maartens G. Isoniazid plus antiretroviral therapy to prevent tuberculosis: a andomized double-blind, placebo-controlled trial. Lancet, 2014, No. 384, pp. 682–690.
Hosseinipour V.C., Bisson G.P., Miyahara S., Sun X., Moses A., Riviere C., Kirui F.K., Badal-Faesen S., Lagat D., Nyirenda M., Naidoo K., Hakim J., Mugyenyi P., Henostroza G., Leger P.D., Lama J.R., Mohapi L., Alave J., Mave V., Veloso V.G., Pillay S., Kumarasamy N., Bao J., Hogg E., Jones L., Zolopa A., Kumwenda J., Gupta A. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label andomized controlled trial. Lancet, 2016, No. 387, pp. 1198–1209.
Samandari T.M., Mosimaneotsile B., Agizew T., Nyirenda S., Tedla Z., Sibanda T., Shang N., Moeti T.L. Randomized, placebo-controlled trial of 6 vs 36 months isoniazid TB preventive therapy for HIV-infected adults in Botswana. Program and Abstracts of Conference on Retroviruses and Opportunistic Infections, San Francisco, US, 16–19 February 2010, pp. 104LB.
Grant A.D., Mngadi K.T., van Halsema C.L., Luttig M.M., Fielding K.L., Churchyard G.J. Adverse events with isoniazid preventive therapy: experience from a large trial. AIDS, 2010, November 24, Suppl. 5, pp. 29–36, DOI: 10.1097/01.aids.0000391019.10661.66..
DOI: 10.1097/01.aids.0000391019.10661.66
Saukkonen J.J., Cohn D.L., Jasmer R.M., Schenker S., Jereb J.A., Nolan C.M., Peloquin C.A., Gordin F.M., Nunes D., Strader D.B., Bernardo J. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am. J. Respir. Crit. Care Med., 2006, Vol. 174, No. 8, pp. 935–952.
Mindachew M., Deribew A., Tessema F., Biadgilign S. Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, Ethiopia. BMC Public Health, 2011, No. 11, pp. 916, DOI:10.1186/1471-2458-11-916..
DOI: 10.1186/1471-2458-11-916